OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $567,000 Stock Position in Inari Medical, Inc. (NASDAQ:NARI)

OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC cut its holdings in Inari Medical, Inc. (NASDAQ:NARI) by 26.5% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 11,102 shares of the company’s stock after selling 3,998 shares during the quarter. OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Inari Medical were worth $567,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Inari Medical by 3.9% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 30,119 shares of the company’s stock worth $1,538,000 after acquiring an additional 1,142 shares during the last quarter. Jefferies Financial Group Inc. bought a new stake in shares of Inari Medical during the 4th quarter valued at approximately $11,183,000. Deutsche Bank AG increased its position in Inari Medical by 13.1% during the 4th quarter. Deutsche Bank AG now owns 136,722 shares of the company’s stock worth $6,980,000 after purchasing an additional 15,823 shares in the last quarter. Crestline Management LP bought a new position in Inari Medical in the 4th quarter valued at approximately $345,000. Finally, Brevan Howard Capital Management LP boosted its position in Inari Medical by 219.0% in the fourth quarter. Brevan Howard Capital Management LP now owns 30,388 shares of the company’s stock valued at $1,551,000 after buying an additional 20,861 shares in the last quarter. 90.98% of the stock is owned by institutional investors and hedge funds.

Inari Medical Stock Performance

NASDAQ NARI opened at $79.97 on Wednesday. The firm’s fifty day moving average price is $79.97 and its two-hundred day moving average price is $70.01. The stock has a market cap of $4.68 billion, a PE ratio of -59.24 and a beta of 1.02. Inari Medical, Inc. has a fifty-two week low of $39.76 and a fifty-two week high of $79.99.

Inari Medical Company Profile

Inari Medical, Inc builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation.